8Heymann WR.Necrobiosis lipoidica treated with topical tretinoin. Cutis . 1996
9Lever,et al.Histopathology of skin. . 1983
二级参考文献12
1[1]Muller SA, Winkelmann RK. Necrobiosis lipoidica diabeticorum.A clinical and pathological investigation of 171 cases [J]. Arch Dermatol, 1966, 93(3): 272-281.
2[2]O'Toole EA, Kennedy U, Nolan JJ, et al. Necrobiosis lipoidica:only a minority of patients have diabetes mellitus[J]. Br J Dermatol, 1999, 140(2): 283-286.
3[3]Quimby SR, Muller SA, Schroeter AL. The cutaneous immunopathology of necrobiosis lipoidica diabeticorum[J]. Arch Dermatol, 1988, 124 (9): 1364-1371.
4[4]Ferringer T, Miller F 3rd. Cutaneous manifestations of diabetes mellitus[J]. Dermatol Clin, 2002, 20(3): 483-492.
5Lowitt MH,Dover JS.Necrobiosis Lipoidiea.J Am Aead Dermatol 1991;25:735-748.
1Clayton TH, Harrison PV. Successful treatment of chronic ulcer- ated necrobiosis lipoidica with 0. 1: topical tacrolimus[J]. Br J Dermatol, 2005,152(3) : 581-582.
2Macaron NC,Cohen C,Chen SC, et al. Gli-1 oncogene is highly expressed in granulomatous skin disorders, including sarcoidosis, granuloma annulare, and necrobiosis lipoidiea diahetieorum[J]. Arch Dermatol,2005,141(2) :259-262.
3Di Gennaro P,Sestini R,Bacci S,et al. Tacrolimus causes reduced GLI1 expression and phenotypie changes in the TE 354. T basal cell carcinoma cell line[J]. Journal of Dermatological Science, 2009,54(1) z52-54.
